Company profile: ElevateBio
1.1 - Company Overview
Company description
- Provider of cell and gene-based therapy solutions, offering cGMP manufacturing and process development through BaseCamp; gene-editing capabilities with Life Edit; integrated technology platforms spanning gene editing, cell therapy enabling technologies, RNA engineering, and delivery; and development of in vivo and ex vivo therapeutic programs leveraging internal R&D and partnerships.
Products and services
- BaseCamp: Delivers cGMP genetic medicine manufacturing and process development, offering end-to-end capabilities for cell and gene therapies and regenerative medicines across development to production
- Integrated Technology Platforms: Combines gene editing, cell therapy enabling technologies, RNA engineering, and delivery platforms into an integrated R&D framework to support therapy development
- Life Edit: Architects a gene-editing platform with RNA-guided nucleases and base editors, delivering a range of editing capabilities for developing genetic therapies
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to ElevateBio
Prime Medicine
HQ: United States
Website
- Description: Provider of gene editing technologies and therapies utilizing Prime Editing to modify genetic sequences to treat a wide range of diseases. Offerings include Prime Editors for precise edits across tissues and cell types, Dual Flap Prime Editing for broader edits, PASSIGE for inserting large gene-sized sequences, and Prime-Edited Cell Therapy.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Prime Medicine company profile →
Sense Biodetection
HQ: United Kingdom
Website
- Description: Provider of molecular diagnostics, developing novel, user-centered handheld tests for infections and oncology, including Veros COVID-19, an instrument-free rapid COVID-19 test delivering results in about 15 minutes at the point of care without the need for specialized laboratory equipment.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Sense Biodetection company profile →
OncoDNA
HQ: Belgium
Website
- Description: Provider of precision medicine for cancer treatment, leveraging over 60 years’ expertise in medical diagnostics and extensive experience in DNA sequencing and diagnostic analyses in oncology.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full OncoDNA company profile →
AmniSure
HQ: United States
Website
- Description: Provider of the AmniSure ROM Test, a one-step, minimally invasive diagnostic strip that uses proprietary technology to detect tiny quantities of amniotic fluid in vaginal discharge. FDA-cleared for marketing, reimbursable under most U.S. state Medicaid plans, and approved in other markets; AmniSure International manufactures, markets, and distributes the test worldwide.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full AmniSure company profile →
Helix
HQ: United States
Website
- Description: Provider of population genomics solutions to advance research and integrate genomic data into clinical care, offering Exome+® sequencing; an integrated platform to collect, sequence, interpret, store, and share genetic information with a DNA product marketplace; Helix Insights; population genomics programs; diagnostic testing for hereditary cancer, cardiovascular disorders, pharmacogenomics, and proactive screening; and large-scale research programs.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Helix company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for ElevateBio
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to ElevateBio
2.2 - Growth funds investing in similar companies to ElevateBio
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for ElevateBio
4.2 - Public trading comparable groups for ElevateBio
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →